久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Ensysce Biosciences Announces Closing of Merger firstwordpharma
    July 01, 2021
    Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ: ENSC) (OTC: ENSCW) today announced that it has closed its previously announced merger with Leisure Acquisition Corp. ("LACQ").
  • “At Home Coronavirus Pill” to Advance to Phase 2 Clinical Development americanpharmaceuticalreview
    May 08, 2021
    Ensysce Biosciences, Inc. announced that Ensysce’s subsidiary, Covistat, will be presenting at the upcoming American Thoracic Society (ATS) Annual Meeting to be held May 14-19, 2021.
  • Recro, Ensysce Expand Development and Manufacturing Partnership contractpharma
    April 16, 2021
    ?Recro Pharma, a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products, has signed additional agreements with an existing ...
PharmaSources Customer Service